RESRPC, INC.Small cap · $1.28B · FY ending 2025-12-31
$5.78+2.30% · 2026-07-13 · EOD
46/100 composite
A transparent blend of the four reads below — each opens into the tool it comes from. Not advice.Quality30
thin moat · ROIC 3%Value56
P/E 38.5 · 41% of 12-mo rangeMomentum46
golden · price below 200-daySmart Money50
quiet · 0 funds · 0P/0S insidersMixed trendGolden crossBelow 200-day
vs S&P 500-11.2%
6-mo excess Trailing performance1M -19.2%
3M -12.7%
6M -2.5%
YTD +4.5%
1Y +11.2%
P/E vs its last 12 months (our price history): 28.2 low → 53.3 high
Current price sits at the 41th percentile of that window — mid-range. We only compare against the price history we own (no paid multi-year multiples — nothing invented).
No clear moat — ROIC 3%
Piotroski F6/9
fundamental strength Altman ZSafe
bankruptcy zone ROIC = NOPAT ÷ (debt + equity − cash), using an effective tax rate of 43%. Annual figures from SEC XBRL.
Dividend & capital return
Payout ratio109.5%
above earnings Shareholder yield3.0%
dividends + buybacks Annual figures from SEC cash-flow statements. Shareholder yield = total cash returned ÷ market cap.
Quiet0P / 0S insiders · 0 funds hold · 0 Congress buys
No recent insider, Congress, or fund activity on file for RES.
Bhealth · 78/100
Self-fundingSelf-funding — profitable · generates cash
No red flags from its filings.
Educational tools — not financial advice. Fundamentals from SEC EDGAR (XBRL); prices are end-of-day (Databento). Scores are a transparent blend of the components shown, computed on our own data — a research aid, not a recommendation.